Prudential Financial’s Definium Therapeutics DFTX Stock Holding History

Prudential Financial’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$729K	Buy	+15,500	New	+$383K	﹤0.01%	1774
2022 Q2	–	Sell	-1,349	Closed	-$22K	–	2725
2022 Q1	$22K	Hold	1,349	–	–	﹤0.01%	2584
2021 Q4	$28K	Sell	1,349 -168	-11%	-$5.36K	﹤0.01%	2609
2021 Q3	$53K	Buy	1,517 +74	+5%	+$3.2K	﹤0.01%	2550
2021 Q2	$75K	Buy	+1,443	New	+$75.7K	﹤0.01%	2505

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Prudential Financial's DFTX Position: Q2 2026 in Review

Prudential Financial opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 15,500 shares worth $729K. The stake represents ﹤0.01% of the portfolio and ranks #1774 among its holdings. This is a return to the name: Prudential Financial previously reported a position in DFTX as recently as Q1 2022.

Prudential Financial first reported a position in DFTX in Q2 2021 and has held it in 5 quarters since. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

Prudential Financial held 15,500 shares of Definium Therapeutics worth $729K as of Q2 2026.
Definium Therapeutics was a new Prudential Financial position in Q2 2026.
Definium Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1774 holding.
Prudential Financial first reported a position in Definium Therapeutics in Q2 2021 and has held it in 5 quarters since.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.